Effect of low-dose aspirin in combination with stable fish oil on whole blood production of eicosanoids

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 64, Issue 6, 2001, Pages 291-297

  Engström, Karin ^a   Wallin, Rolf ^a   Saldeen, Tom ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; FISH OIL; ICOSANOID; LEUKOTRIENE B4; PROSTACYCLIN; THROMBOXANE A2;

ADULT; ARTICLE; BLOOD; BLOOD ANALYSIS; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; ICOSANOID METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL;

EID: 0034932947     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0275     Document Type: Article

References (40)

1. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
2. 2 and prostacyclin
3. Heart disease, aspirin, and fish oil
4. Inhibition of prostaglandin as a mechanism of action for aspirin-like drugs
5. Recovery of endothelial cell prostacyclin production after inhibition by low dose of aspirin
6. Inhibition of prostacyclin by treatment of endothelium with aspirin
7. 2 after low dose aspirin
8. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
9. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients
10. Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift
11. Fish oils in cardiovascular disease
12. Long term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function and eicosanoid formation in humans
13. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus
14. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production
15. Cardiovascular effects of n-3 fatty acids
16. 3 are formed in man after dietary eicosapentaenoic acid: Identification and quantification by capillary gas chromatography-electron impact mass spectrometry
17. Influence of dietary fish on eicosanoid metabolism in man
18. 3 levels
19. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vivo neutrophil and monocyte leukotriene generation and neutrophil function
20. 5, thromboxane and platelet activating factor by rat leukocytes
21. The generation and metabolism of leukotrienes in the ionophorestimulated blood of normal and asthmatic subjects
22. Oxidation of n-3 fatty acids
23. N-3 fatty acids and ischemic heart disease
24. Physiologic variables affecting thromboxane B, production in human whole blood
25. Reverse-phase high-performance liquid chromatography analysis of arachidonic acid metabolites in plasma after stimulation of whole blood ex vivo
26. 4 after dietary fish oil supplementation in man: Effect of vitamin E
27. Thromboxane production in umbilical vein grafts
28. Analysis of 2- and 3-series prostanoids by post HPLC ELISA
29. 1α antibodies
30. 17-6-keto-PGF1α
31. Effects of changes in fat, fish and fibre intakes on death myocardial reinfarction: Diet and reinfarction trial (DART)
32. Dietary supplementation with n-3 poly-unsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
33. Effect of acute administration of fish oil (omega-3 marine triglyceride) on gastric ulceration and secretion induced by various ulcerogenic and necrotizing agents in rats
34. Protective effects of the prostaglandins on the gastric mucosa
35. Mechanism of action of nonsteroidal anti-inflammatory drugs
36. Aspirin and asthma
37. N-3 fatty acids do not prevent restenosis after coronary angioplasty: Results from the CART study. Coronary Angioplasty Restenosis Trial